Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy
Condition: Rheumatoid Arthritis Intervention: Sponsors: TcLand Expression S.A.; Premier Research Group plc; Theradis pharma; Medpharmgene Inc. Recruiting - verified July 2011